Abstract:Background: Regulating epithelial-to-mesenchymal transition (EMT) in cancer cells has been widely considered as an approach to combat cancer progression and therapeutic resistance, whereas a limited number of broadly comprehensive investigations of miRNAs involved in metastatic colorectal cancer (mCRC) have been conducted. In this study, we investigated the roles and mechanisms of EMT process in mCRC. Methods: We used ISH and RT-qPCR to measure expression of miR93 in CRC tissues, nontumor tissues and metastatic liver tissues. CRC cell lines were transduced with lentiviruses expressed miR93. Its inhibitor sequence targeted miR93 or a scrambled sequence (control). Proliferation, metastasis, invasion and colony formation and growth of CRC cells which overexpress miR93 or its inhibitor in severe combined immune-deficient mice were analysed. Western blot, and luciferase assays were used to measure expression of Eph tyrosine kinase receptor (EphA4) and related signalling molecules. Results: In this study, we demonstrated that miR93 regulated EMT process by targeting EphA4 in mCRC. CRC tissues and metastatic liver tissues had increased levels of miR93 compared with the nontumor tissues and cells, and miR93 can regulate EMT process. Overexpression of miR93 increased proliferation of CRC cells, metastasis, invasion and colony formation in vitro, whereas miR93 depletion reduced these parameters. In nude mice, overexpression of miR93 by CRC cells increased liver metastasis and overexpression of the miR93 inhibitor reduced it. Then we identified by microarray analysis that the direct and functional target genes of miR93 was EphA4. Knockdown of EphA4 phenocopied the effect of miR-93 and ectopic expression of EphA4 restored the effect of miR93 on proliferation, migration, invasion and liver metastasis in CRC cells. Conclusions: Our findings revealed miR93 regulates EMT process by targeting EphA4 to affect liver metastasis in CRC. miR93 inhibited tumor metastasis by directly targeting EphA4, a crucial factor in regulating EMT. Collectively, this study provides new insights into exploring the therapeutic potential of miR93, which is able to regulate EMT process to affect tumor metastasis, and warrant further study in clinical settings. Clinical trial indentification: The present study was supported in part by grants from the Health and Family Planning Commission of Shanxi Province (No.2015049), the Applied Basic Research Programs of Shanxi Science and Technology Department (No.201601D011128). Legal entity responsible for the study: The Health and Family Planning Commission of Shanxi Province, the Applied Basic Research Programs of Shanxi Science and Technology Department Funding: The Health and Family Planning Commission of Shanxi Province, the Applied Basic Research Programs of Shanxi Science and Technology Department Disclosure: All authors have declared no conflicts of interest.

Hsa-Mir-93 Regulates MUCIN Family Gene Expression Via WNT/β-catenin Pathway in Intrahepatic Stone Disease

Mir-301A-3p Promotes Hepatic Stellate Cells Activation and Liver Fibrogenesis Via Regulating PTEN/PDGFR-β.

Mirna-34A Inhibits Cell Adhesion by Targeting CD44 in Human Renal Epithelial Cells: Implications for Renal Stone Disease

MiR-337 Suppresses Pancreatic Cancer Development Via STAT3/Wnt/β-catenin Axis.

The Role of Mir-99B in Mediating Hepatocellular Carcinoma Invasion and Migration.

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

Lps Increases Muc5ac By Tace/Tgf-Alpha/Egfr Pathway In Human Intrahepatic Biliary Epithelial Cell

miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients

Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinoma

Micro ribonucleic acid-93 promotes oncogenesis of cervical cancer by targeting RAB11 family interacting protein 1.

MiR-93/HMGB3 regulatory axis exerts tumor suppressive effects in colorectal carcinoma cells

The miR-3074/BMP7 axis regulates TGF-β-caused activation of hepatic stellate cells in vitro and CCl4-caused murine liver fibrosis in vivo

Utility of Mir‑133a‑3p As a Diagnostic Indicator for Hepatocellular Carcinoma: an Investigation Combined with GEO, TCGA, Meta‑analysis and Bioinformatics.

Mir-93 Regulates Epithelial-to-mesenchymal Transition Process in Metastatic Colorectal Cancer by Targeting EphA4

Role of Secretory Mucins in the Occurrence and Development of Cholelithiasis

Overexpression of Mirna-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma Via Inhibition of KLF9

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

An integrated analysis of differential miRNA and mRNA expressions in human gallstones.

microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit

MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer

MUC13 Promotes Intrahepatic Cholangiocarcinoma Progression Via EGFR/PI3K/AKT Pathways